Related references
Note: Only part of the references are listed.Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells
Zhijiu Zhong et al.
CANCER RESEARCH (2010)
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7
Surabhi Dangi-Garimella et al.
EMBO JOURNAL (2009)
Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells
I. Fon Bambang et al.
EXPERIMENTAL CELL RESEARCH (2009)
Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function?
Maja Herak Bosnar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
The iron-regulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets
Zaklina Kovacevic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
Thomas P. Ellen et al.
CARCINOGENESIS (2008)
The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-Cadherin
Sushant K. Kachhap et al.
PLOS ONE (2007)
Iron chelation and regulation of the cell cycle:: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion
Dong Fu et al.
BLOOD (2007)
Loss of nuclear p21Cip1/WAF1 during neoplastic progression to metastasis in γ-irradiated p21 hemizygous mice
Robert W. Engelman et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells
Lan Chun Tu et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer
Sucharita Bandyopadhyay et al.
CANCER RESEARCH (2006)
The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis
L. L. Dunn et al.
CARCINOGENESIS (2006)
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis
Yuichiro Maruyama et al.
CANCER RESEARCH (2006)
A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis
James M. Woods et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Metastasis suppressor genes - From gene identification to protein function and regulation
JC Berger et al.
CANCER BIOLOGY & THERAPY (2005)
DNA-binding and transactivation activities are essential for TAp63 protein degradation
HQ Ying et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Drg1 expression in 131 colorectal liver metastases:: Correlation with clinical variables and patient outcomes
MA Shah et al.
CLINICAL CANCER RESEARCH (2005)
Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate
K Hastak et al.
FASEB JOURNAL (2005)
MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53
Z Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan et al.
BLOOD (2004)
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3
JT Murray et al.
BIOCHEMICAL JOURNAL (2004)
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
S Bandyopadhyay et al.
ONCOGENE (2004)
The chemokine system - a major regulator of angiogenesis in health and disease
MM Rosenkilde et al.
APMIS (2004)
NDRG1 is necessary for p53-dependent apoptosis
S Stein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation
NTV Le et al.
BLOOD (2004)
N-myc downregulated gene 1 is a phosphorylated protein in mast cells
T Sugiki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
YT Jin et al.
EMBO JOURNAL (2003)
The effect of potent iron chelators on the regulation of p53:: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1
SX Liang et al.
CARCINOGENESIS (2003)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)
MMP9 potentiates pulmonary metastasis formation
LCL van Kempen et al.
CANCER CELL (2002)
Alternative and aberrant splicing of MDM2 mRNA in human cancer
F Bartel et al.
CANCER CELL (2002)
Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family
XH Qu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression
J Gao et al.
BLOOD (2001)
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
SC Evans et al.
ONCOGENE (2001)
Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1
J Taplick et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)